Literature DB >> 2554330

Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin.

S Vukicevic1, F P Luyten, A H Reddi.   

Abstract

Osteogenin was recently purified and the amino acid sequences of tryptic peptides were determined. Osteogenin in conjunction with insoluble collagenous bone matrix induces cartilage and bone formation in vivo. To understand the mechanism of action of osteogenin, we examined its influence on periosteal cells, osteoblasts, fibroblasts, chondrocytes, and bone marrow stromal cells in vitro. Osteogenin stimulated alkaline phosphatase activity and collagen synthesis in periosteal cells. The cAMP response to parathyroid hormone in periosteal cells was increased by osteogenin. In primary cultures of calvarial osteoblasts, osteogenin stimulated alkaline phosphatase activity, the cAMP response to parathyroid hormone, and the synthesis of collagenous and noncollagenous proteins; however, cell proliferation was not affected. Osteogenin increased the production of sulfated proteoglycans in fetal rat chondroblasts and in rabbit articular chondrocytes. The present experiments demonstrate the significant influence of osteogenin in the stimulation of osteogenic and chondrogenic phenotypes in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554330      PMCID: PMC298376          DOI: 10.1073/pnas.86.22.8793

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations.

Authors:  C G Bellows; J E Aubin; J N Heersche; M E Antosz
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

2.  Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro.

Authors:  D M Rosen; S A Stempien; A Y Thompson; S M Seyedin
Journal:  J Cell Physiol       Date:  1988-03       Impact factor: 6.384

3.  Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography.

Authors:  T K Sampath; N Muthukumaran; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Proteoglycans: isolation and purification from tissue cultures.

Authors:  M Yanagishita; R J Midura; V C Hascall
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers.

Authors:  A J Friedenstein; R K Chailakhyan; U V Gerasimov
Journal:  Cell Tissue Kinet       Date:  1987-05

6.  Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor.

Authors:  S B Rodan; G Wesolowski; K Thomas; G A Rodan
Journal:  Endocrinology       Date:  1987-12       Impact factor: 4.736

7.  Talc granulomatosis in the rat: the relationship between osteoblast insufficiency and adjacent bone marrow hyperplasia.

Authors:  S Vukicević; A Marusić; A Stavljenić; N Cicak; M Vogel; B Krempien
Journal:  Exp Hematol       Date:  1988-10       Impact factor: 3.084

8.  Collagen expression, ultrastructural assembly, and mineralization in cultures of chicken embryo osteoblasts.

Authors:  L C Gerstenfeld; S D Chipman; C M Kelly; K J Hodgens; D D Lee; W J Landis
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

9.  Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F.

Authors:  M E Owen; J Cavé; C J Joyner
Journal:  J Cell Sci       Date:  1987-06       Impact factor: 5.285

10.  Induction of chondrogenesis in limb mesenchymal cultures by disruption of the actin cytoskeleton.

Authors:  N C Zanetti; M Solursh
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

View more
  35 in total

1.  Transforming growth factor-beta: its effect on phenotype reexpression by dedifferentiated chondrocytes in the presence and absence of osteogenin.

Authors:  E T Harrison; F P Luyten; A H Reddi
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

Review 2.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Authors:  Slobodan Vukicevic; Hermann Oppermann; Donatella Verbanac; Morana Jankolija; Irena Popek; Jasna Curak; Jelena Brkljacic; Martina Pauk; Igor Erjavec; Igor Francetic; Ivo Dumic-Cule; Mislav Jelic; Dragan Durdevic; Tomislav Vlahovic; Ruder Novak; Vera Kufner; Tatjana Bordukalo Niksic; Marija Kozlovic; Zrinka Banic Tomisic; Jadranka Bubic-Spoljar; Ivancica Bastalic; Smiljka Vikic-Topic; Mihaela Peric; Marko Pecina; Lovorka Grgurevic
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

3.  An in vitro bioassay to assess biological activity in demineralized bone.

Authors:  L Wolfinbarger; Y Zheng
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

4.  Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts.

Authors:  A Chaudhari; E Ron; M P Rethman
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

5.  Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis.

Authors:  Lovorka Grgurevic; Boris Macek; David R Healy; Amy L Brault; Igor Erjavec; Antonio Cipcic; Ivica Grgurevic; Dunja Rogic; Kresimir Galesic; Jelena Brkljacic; Ranka Stern-Padovan; Vishwas M Paralkar; Slobodan Vukicevic
Journal:  J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 10.121

6.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins.

Authors:  B L Rosenzweig; T Imamura; T Okadome; G N Cox; H Yamashita; P ten Dijke; C H Heldin; K Miyazono
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes.

Authors:  Hee-Jeong Im; Carol Pacione; Susan Chubinskaya; Andre J Van Wijnen; Yubo Sun; Richard F Loeser
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

8.  Temporal changes during bone regeneration in the calvarium induced by osteogenin.

Authors:  L J Marden; N C Quigley; A H Reddi; J O Hollinger
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

9.  Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression.

Authors:  N S Cunningham; V Paralkar; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects.

Authors:  L J Marden; R S Fan; G F Pierce; A H Reddi; J O Hollinger
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.